Kramer Hilary
Transaction: 09/04/2025
BUY
Change
+31,250
Price
$1.33
Filing
09/08/2025
Type
BUY
GT Biopharma, Inc.
GTBP • Biotechnology
$7.31
▲ +0.62 (+9.27%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$283.78M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 3.5Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$7.31
Change9.27%
Shares Out38.82M
Market Cap$283.78M
Enterprise Value$278.82M
52W Range0.26 - 1.53
Beta0.90
P/E-12.85
P/B79.51
P/FCF-19.67
EV/EBITDA-17.07
EV/FCF-19.33
Price$7.31
Change9.27%
Shares Out38.82M
Market Cap$283.78M
Enterprise Value$278.82M
52W Range0.26 - 1.53
Beta0.90
P/E-12.85
P/B79.51
P/FCF-19.67
EV/EBITDA-17.07
EV/FCF-19.33
Earnings Yield-7.78%
FCF Yield-5.08%
Dividend Yield0.65%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio3.50
Quick Ratio3.50
Revenue 5Y-100.00%
Volume628.22K
Avg Volume1.21M
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 3.5Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-10-21
90/100
Bullish
Bullish
4
Hold
1
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
CASAMENTO CHARLES J
Transaction: 09/04/2025
BUY
Change
+62,500
Price
$1.33
Filing
09/08/2025
Type
BUY
URBAN ALAN LOUIS
Transaction: 09/04/2025
BUY
Change
+50,000
Price
$1.33
Filing
09/08/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kramer Hilary | BUY | +31,250 | $1.33 | 09/04/2025 | 09/08/2025 |
| CASAMENTO CHARLES J | BUY | +62,500 | $1.33 | 09/04/2025 | 09/08/2025 |
| URBAN ALAN LOUIS | BUY | +50,000 | $1.33 | 09/04/2025 | 09/08/2025 |
| Breen Michael Martin | BUY | +100,000 | $1.33 | 09/04/2025 | 09/08/2025 |
| Mun-Gavin David C. | BUY | +31,250 | $1.33 | 09/04/2025 | 09/08/2025 |
| Mun-Gavin David C. | OTHER | 0 | Not reported | 06/10/2025 | 07/30/2025 |
| Kramer Hilary | OTHER | 0 | Not reported | 05/07/2025 | 06/03/2025 |
| Ritter Andrew J | OTHER | 0 | Not reported | 05/08/2025 | 05/29/2025 |
| URBAN ALAN LOUIS | BUY | +23,335 | $2.11 | 10/17/2024 | 10/21/2024 |
| URBAN ALAN LOUIS | OTHER | 0 | Not reported | 06/03/2024 | 06/13/2024 |
| Ohri Manu | SELL | -200,000 | $0.29 | 08/11/2023 | 08/15/2023 |
| Breen Michael Martin | BUY | +200,000 | $0.29 | 08/11/2023 | 08/15/2023 |
| CASAMENTO CHARLES J | BUY | +500,000 | $0.35 | 06/16/2023 | 06/21/2023 |
| CASAMENTO CHARLES J | OTHER | 0 | Not reported | 05/01/2023 | 05/04/2023 |
| Breen Michael Martin | BUY | +50,000 | $0.50 | 04/11/2023 | 04/11/2023 |
| Ohri Manu | BUY | +50,000 | $0.50 | 04/06/2023 | 04/10/2023 |
| Wendel Bruce | BUY | +500,000 | $0.84 | 01/27/2023 | 02/01/2023 |
| Ohri Manu | BUY | +500,000 | $0.84 | 01/27/2023 | 02/01/2023 |
| SHROTRIYA RAJESH C MD | BUY | +500,000 | $0.84 | 01/27/2023 | 02/01/2023 |
| Breen Michael Martin | BUY | +500,000 | $0.84 | 01/27/2023 | 02/01/2023 |